
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Rare Cancer Research Foundation Partners with Spanios to Advance Cancer Research
Details : The partnership with Spanios will catalyze the discovery of new biomarkers and validate therapeutic approaches previously inaccessible to rare cancer patients.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
April 04, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery
Sponsor : Unravel Biosciences
Deal Size : Undisclosed
Deal Type : Partnership
Unravel Biosciences Partners with Spanios to Discover Therapeutic Targets for Rare Cancer
Details : The partnership combines Unravel's proprietary gene regulatory network and drug-gene interaction network model of human health and drug response with Spanios's patient-derived tumoroids (PDTs) to discover novel therapeutic targets for rare cancers.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
November 08, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery
Sponsor : Unravel Biosciences
Deal Size : Undisclosed
Deal Type : Partnership
